Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice - eBioMedicine

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

A rare case of IgG4‐associated disease caused by COVID‐19: Case report and literature review - Xu - International Journal of Rheumatic Diseases - Wiley Online Library

Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals, BMC Medicine

Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies - ScienceDirect

The Changing Trajectory of Covid-19 and How Immunity is Evolving with It - Article (Preprint v1) by Azizul Haque et al.

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

3rd Pfizer Vaccine Shot Increases Non-inflammatory IgG4

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination